Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Biomx Inc PHGE

Alternate Symbol(s):  PHGEW | PHGE.U

Healthcare Biotechnology
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:PHGE)

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

GlobeNewswire 3 days ago

BiomX Announces the Appointment of Susan Blum to its Board of Directors

GlobeNewswire 8 days ago

BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

GlobeNewswire April 4, 2024

BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire April 3, 2024

BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024

GlobeNewswire March 27, 2024

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

GlobeNewswire March 18, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating BiomX Inc. Buyout

Newsfile March 8, 2024

Shareholder Alert: Ademi LLP investigates the transaction between BiomX Inc. and Adaptive Phage Therapeutics

PR Newswire March 7, 2024

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing

GlobeNewswire March 6, 2024
View More News ››

Opinion & Analysis (NYSEAM:PHGE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:PHGE)

Why BiomX Stock Is Surging Today | Benzinga

News; $PHGE Why BiomX Stock Is Surging Today | BenzingaBiomX Inc. (AMEX:PHGE) shares are trading higher Wednesday after the company...
whytestocks - March 6, 2024

BiomX Agrees to Merge with Adaptive Phage Therapeutics and C

News; $PHGE BiomX Agrees to Merge with Adaptive Phage Therapeutics and Concurrent $50 M Financing2024-03-06 08:09:27 ET DENVER, Colo...
whytestocks - March 6, 2024

BiomX Announces Entry into Merger Agreement with Adaptive Ph

News; $PHGE BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing...
whytestocks - March 6, 2024

BiomX Announces Entry into Merger Agreement with Adaptive Ph

Just In: $PHGE BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million...
whytestocks - March 6, 2024
View more Bullboard ››

Vertex Resource Group Ltd.

Vertex Resource Group Ltd.

Vertex Resource Group Ltd. is a Canada-based provider of environmental and industrial services. It provides environmental ...
View More »